| Entry |
|
|---|
| Name |
Amfepramone (INN);
Diethylpropion (BAN) |
|---|
| Formula |
C13H19NO
|
|---|
| Exact mass |
205.1467
|
|---|
| Mol weight |
205.2961
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
|
|---|
| Remark |
| Product (DG00104): | D03801<US> |
|
|---|
| Efficacy |
Appetite suppressant |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08AA Centrally acting antiobesity products
A08AA03 Amfepramone
D07444 Amfepramone (INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
DG00104 Amfepramone
D07444 Amfepramone
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D07444 Amfepramone (INN)
SLC6A3 (DAT1)
D07444 Amfepramone (INN)
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Cabinet order Article 3 (78 substances)
D07444
Drug groups [BR:br08330]
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
DG00104 Amfepramone
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C8y C 16.8000 -16.5200
2 C5a C 17.9900 -15.8200
3 C8x C 15.6100 -15.8200
4 C8x C 16.8000 -17.9200
5 C1c C 19.2500 -16.5200
6 O5a O 17.9900 -14.4200
7 C8x C 14.3500 -16.5200
8 C8x C 15.6100 -18.6200
9 N1c N 20.4400 -15.8200
10 C1a C 19.2500 -17.9200
11 C8x C 14.3500 -17.9200
12 C1b C 21.6300 -16.5200
13 C1b C 20.4400 -14.4200
14 C1a C 22.8900 -15.8200
15 C1a C 21.6300 -13.7200
BOND 15
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 2
6 3 7 1
7 4 8 2
8 5 9 1
9 5 10 1
10 7 11 2
11 9 12 1
12 9 13 1
13 12 14 1
14 13 15 1
15 8 11 1
|
|---|
